arrow
M

Marina Naldi

university of bologna
H指数:27
被引数:2,003

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Exopolysaccharides of Lactobacillus crispatus mediate key balancing interactions with the vaginal mucosa

屎肠球菌胞外多糖介导与阴道黏膜的关键平衡相互作用

2026-02-191
OA
Repurposing SGLT2 and DPP-4 inhibitors for mild cognitive impairment in type 2 diabetes mellitus: Insights from proteomics, target prediction and molecular docking
2026-01-260
PRE
HSA-nanobinders crafted from bioresponsive prodrugs for combined cancer chemoimmunotherapy-an in vitro exploration

由生物反应性前药制成的用于联合癌症化学免疫疗法的HSA-纳米结合剂-体外探索

2024-03-272
OAAI
Discovery of the 4-aminopiperidine-based compound EM127 for the site-specific covalent inhibition of SMYD3

基于4-氨基哌啶的化合物EM127对SMYD3的位点特异性共价抑制作用的发现

2022-12-019
PRE
Discovery and In Vivo Proof of Concept of a Highly Potent DualInhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase forthe Treatment of Alzheimer's Disease
2022-03-1031
OAAI
From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects
2021-12-0112
OAAI
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications

失代偿期肝硬化患者有效白蛋白的测定: 临床和预后意义

2021-05-2656
OAAI
Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties
2021-01-0112
OAAI
Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors

他克林-O-保护的酚类异二聚体作为抗阿尔茨海默氏病的多靶点定向配体: 选择性亚纳摩尔BuChE抑制剂

2019-11-0129
OAAI